Exouza Completes Landmark PBM Study for Alabama Legislature

Study documents PBM practices and impacts with comprehensive state-specific analysis, insights and recommendations.

Exouza’s PBM report provides the most in depth analysis of PBM practices and impacts, leveraging industry viewpoints and the most comprehensive state-specific assessment of pharmacy and care deserts, drug reimbursement and impacts to pharmacies.

This report equips legislators with evidence-based insights, policy analysis, and key recommendations for a fair and balanced approach at improving pharmacy viability, consumer access and transparency while promoting plan sponsor flexibility and cost containment.

Alabama Legislature reviewing PBM study findings

Key Takeaways:

• PBMs provide tens of billions of dollars in value but the amount and distribution of this value is still highly opaque and concerning to customers, pharmacies, and other stakeholders.  

• PBM vertical integration strategies are expanding, including manufacturing biosimilars, and further widen the value – opacity gap.

• Alabama legislation provides an estimated half a billion dollars in relief to pharmacies but continued lower reimbursement has resulted in net decline in pharmacies for five consecutive years, leaving nearly a quarter of Alabamians in pharmacy deserts.

• Alabama pharmacies have shown market resilience but additional support through targeted incentives and tax credits aimed at promoting pharmacy viability in pharmacy and care deserts may be an effective, fair and balanced approach.

To learn more and access Exouza’s landmark PBM practices and impacts report, click here: Exouza Report on PBM Practices and Impacts